Al-Dawaa Medical Services Company (TADAWUL: 4163)
Saudi Arabia
· Delayed Price · Currency is SAR 79.20
+2.20 (2.86%)
Dec 3, 2024, 3:18 PM AST
Al-Dawaa Medical Services Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 6,187 | 5,741 | 5,372 | 5,034 | 4,962 | 3,962 | Upgrade
|
| Revenue Growth (YoY) | 7.76% | 6.87% | 6.71% | 1.46% | 25.23% | 4.35% | Upgrade
|
| Cost of Revenue | 3,993 | 3,677 | 3,397 | 3,172 | 3,111 | 2,405 | Upgrade
|
| Gross Profit | 2,194 | 2,065 | 1,975 | 1,863 | 1,851 | 1,557 | Upgrade
|
| Selling, General & Admin | 1,688 | 1,591 | 1,606 | 1,598 | 1,461 | 1,256 | Upgrade
|
| Other Operating Expenses | 4.5 | 4.5 | 0.66 | - | - | - | Upgrade
|
| Operating Expenses | 1,693 | 1,596 | 1,607 | 1,598 | 1,461 | 1,256 | Upgrade
|
| Operating Income | 500.95 | 468.92 | 368.54 | 264.37 | 389.85 | 300.61 | Upgrade
|
| Interest Expense | -117.49 | -118.32 | -52.6 | -13.2 | -145.04 | -78.39 | Upgrade
|
| Interest & Investment Income | 0.73 | 0.73 | 4.9 | 6.52 | 3.33 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -2 | -2 | -1.02 | -9.04 | -3.32 | 8.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.67 | - | - | -2.96 | 12.74 | 16.66 | Upgrade
|
| EBT Excluding Unusual Items | 384.86 | 349.33 | 319.82 | 245.68 | 257.56 | 246.95 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.1 | 1.1 | 3.01 | 0.59 | 0.64 | 0.55 | Upgrade
|
| Asset Writedown | -5.78 | -5.78 | -7.84 | -1.65 | - | -7.84 | Upgrade
|
| Other Unusual Items | -4.62 | -4.62 | 2.69 | 1.26 | 2.45 | 3.73 | Upgrade
|
| Pretax Income | 377.94 | 342.4 | 317.87 | 246.02 | 261.09 | 243.98 | Upgrade
|
| Income Tax Expense | 19.29 | 13.18 | 12.42 | 6.87 | 14.66 | 10.77 | Upgrade
|
| Net Income | 358.65 | 329.22 | 305.45 | 239.14 | 246.44 | 233.2 | Upgrade
|
| Net Income to Common | 358.65 | 329.22 | 305.45 | 239.14 | 246.44 | 233.2 | Upgrade
|
| Net Income Growth | 9.88% | 7.78% | 27.73% | -2.96% | 5.67% | 2.13% | Upgrade
|
| Shares Outstanding (Basic) | 85 | 85 | 85 | 85 | 85 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 85 | 85 | 85 | 85 | 85 | 0 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 42400.00% | - | Upgrade
|
| EPS (Basic) | 4.22 | 3.87 | 3.59 | 2.81 | 2.90 | 1166.02 | Upgrade
|
| EPS (Diluted) | 4.22 | 3.87 | 3.59 | 2.81 | 2.90 | 1166.02 | Upgrade
|
| EPS Growth | 9.88% | 7.78% | 27.73% | -2.96% | -99.75% | - | Upgrade
|
| Free Cash Flow | 414.62 | 508.97 | 532.99 | 368.04 | 176.22 | 359.39 | Upgrade
|
| Free Cash Flow Per Share | 4.88 | 5.99 | 6.27 | 4.33 | 2.07 | 1796.93 | Upgrade
|
| Dividend Per Share | 2.500 | 2.500 | 2.500 | 4.130 | - | 755.000 | Upgrade
|
| Dividend Growth | 0% | 0% | -39.47% | - | - | 8.63% | Upgrade
|
| Gross Margin | 35.46% | 35.96% | 36.76% | 37.00% | 37.31% | 39.30% | Upgrade
|
| Operating Margin | 8.10% | 8.17% | 6.86% | 5.25% | 7.86% | 7.59% | Upgrade
|
| Profit Margin | 5.80% | 5.73% | 5.69% | 4.75% | 4.97% | 5.89% | Upgrade
|
| Free Cash Flow Margin | 6.70% | 8.86% | 9.92% | 7.31% | 3.55% | 9.07% | Upgrade
|
| EBITDA | 662.43 | 625.06 | 520.59 | 415.09 | 532.97 | 447.31 | Upgrade
|
| EBITDA Margin | 10.71% | 10.89% | 9.69% | 8.24% | 10.74% | 11.29% | Upgrade
|
| D&A For EBITDA | 161.48 | 156.14 | 152.05 | 150.72 | 143.12 | 146.7 | Upgrade
|
| EBIT | 500.95 | 468.92 | 368.54 | 264.37 | 389.85 | 300.61 | Upgrade
|
| EBIT Margin | 8.10% | 8.17% | 6.86% | 5.25% | 7.86% | 7.59% | Upgrade
|
| Effective Tax Rate | 5.10% | 3.85% | 3.91% | 2.79% | 5.61% | 4.41% | Upgrade
|
| Advertising Expenses | - | 24.13 | 24.24 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.